BlackRock, Inc.NYSE: BLK

Major shareholder announcement - BlackRock, Inc.

· Issued by BlackRock, Inc.

Summary by 6ix AI

BlackRock, Inc. told ChemoMetec A/S that on September 14, 2026 it increased its total holding in ChemoMetec A/S to 15.00%, reaching the 15 per cent reporting limit under Section 38 of the Capital Markets Act.

Key details

  • ChemoMetec A/S, which develops, manufactures and markets instruments for cell counting and other measurements, disclosed the holding on September 16, 2026 under Section 30 of the Capital Markets Act.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/major-shareholder-announcement-blackrock-inc

Watch BlackRock's latest callBlackRock (NYSE:BLK) Q3 2026 Earnings Call · Replay · Oct 14Read the transcript of BlackRock (NYSE:BLK) Q3 2026 Earnings Call

16 September 2026
ANNOUNCEMENT NO. 315

Major shareholder announcement - BlackRock, Inc.

Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock, Inc., on 14 September 2026, increased its total holding in ChemoMetec A/S to 15.00%, and that the holding thus has reached the 15 per cent limit in Section 38 of the Capital Markets Act.

Additional information

Martin Helbo Behrens, CEO
Tel.: (+45) 81 10 06 80

Phillip Massie Price, CFO
Tel.: (+45) 81 10 06 80

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements.
ChemoMetec's instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec's customers include some of the world's leading pharmaceutical companies.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.

BlackRock, Inc. on 6ix

Earlier from BlackRock

Later from BlackRock

All BlackRock news releases